Wanyan Ouyang
State Key Laboratory Of Medical Genomics
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Metabolic biomarkers for predicting onset and severity of CAR-T therapy-induced cytokine release syndrome in multiple myeloma.
Journal: Frontiers of medicine
Published: August 01, 2025
Efficacy of novel therapies for refractory and relapsed multiple myeloma in China.
Journal: Chinese medical journal
Published: June 07, 2025
Challenges facing CAR T-cell immunotherapy in multiple myeloma.
Journal: Critical reviews in oncology/hematology
Published: April 21, 2025
Prognostic value of [18F]fluorodeoxyglucose-PET/MRI(CT) novel interpretation criteria (IMPeTUs) in multiple myeloma.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 22, 2024
Efficacy and safety of olverembatinib in adult BCR::ABL1-positive ALL with T315I mutation or relapsed/refractory disease.
Journal: British journal of haematology
Published: June 11, 2024
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion.
Journal: Journal for immunotherapy of cancer
Published: March 18, 2024
Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma.
Journal: BMC cancer
Published: November 09, 2023
Aptamers in hematological malignancies and their potential therapeutic implications.
Journal: Critical reviews in oncology/hematology
Published: February 05, 2016
Mutations in the D1 domain of von Willebrand factor impair their propeptide-dependent multimerization, intracellular trafficking and secretion.
Journal: Journal of hematology & oncology
Published: May 17, 2015
Last Updated: 09/26/2026